DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MediPoint: Peripheral Vascular Interventions - Global Analysis and Market Forecasts" report to their offering.
The peripheral vascular interventions market is a dynamic, billion-dollar market with solid growth potential through 2022. The rising prevalence of peripheral artery disease (PAD) combined with the increasing endovascular procedure rate will ensure that the market will continue to expand in the coming years.
Recent technological advancements within this space, including drug-eluting stents and balloons, bioabsorbable stents (BAS), and polytetrafluoroethylene (PTFE)-covered stents have the potential to revolutionize the future of PAD treatment, as these devices provide improved solutions for complex pathologies.
The technologies covered in this report include lower extremity stents, percutaneous transluminal angioplasty (PTA) balloons, PTA drug-eluting balloons (DEB), carotid stents, and renal stents. This report focuses on the global peripheral vascular interventions market in North America (Canada, Mexico, US), Europe (France, Germany, Italy, Spain, Russia, UK), Asia-Pacific (APAC) (Australia, China, India, Japan, South Korea), and South America (Brazil).
This report provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players, and market analysis of each segment. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using and evaluating the adoption of different technologies.
Key Topics Covered:
1 Tables & Figures
3 Market Access
4 Unmet Needs and Market Opportunity Analysis
5 Competitive Assessment
6 Market Outlook
- Abbott Vascular
- Boston Scientific
- C.R. Bard
- Cook Medical
- Cordis (Cardinal Health)
For more information visit http://www.researchandmarkets.com/research/b8zzzl/medipoint